fig3
![Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease](https://image.oaes.cc/054d92d3-a431-4da4-86b2-5d5b8fc82df3/hr30134.fig.3.jpg)
Figure 3. Hepatic and extrahepatic complications of MASLD. MASLD: Metabolic Dysfunction-associated Steatotic Liver disease, CVD: Cardiovascular Disease; CKD: Chronic Kidney Disease; HCC: Hepatocellular Carcinoma; CCA: Cholangiocarcinoma; IBD: Inflammatory Bowel Disease.